<?xml version="1.0" encoding="UTF-8"?>
<p>To evaluate the sensitivity of these molecular and serologic tests for diagnosing WNV in humans, we used the same methods to test 9 archived sequential serum samples in parallel (Table 
 <xref ref-type="table" rid="T2">2</xref>). The samples were from a patient with WNV encephalitis who became infected with neuroinvasive lineage 2 WNV strain in 2003 after a needlestick injury (
 <xref ref-type="bibr" rid="R11">11</xref>). Samples were collected 0â€“30 days after exposure. Initial symptoms developed on postexposure day 7 and persisted for 19 days; the patient completely recovered by day 26 (
 <xref ref-type="bibr" rid="R11">11</xref>). 
</p>
